Introduction Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system that leads to neurological disability, more pronounced in the progressive phase. Teriflunomide, an oral disease-modifying therapy, has shown potential neuroprotective effects beyond relapse reduction, including preserva...
F. Mahmoudi, Nicole Baldwin, Ramon Flores Gonzalez et al.· Frontiers in Neurology· 0 citations